Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Concert Pharmaceuticals Inc. (CNCE)

10.87   -0.17 (-1.54%) 02-14 16:00
Open: 11.04 Pre. Close: 11.04
High: 11.33 Low: 10.85
Volume: 71,149 Market Cap: 321M
Concert Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It aims to discover and develop small-molecule drugs for new treatments to cure cystic fibrosis, inflammation, narcolepsy, residual schizophrenia, and Alzheimer's agitation.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.343 - 11.403 11.403 - 11.454
Low: 10.711 - 10.778 10.778 - 10.834
Close: 10.762 - 10.874 10.874 - 10.969

Technical analysis

as of: 2020-02-14 4:27:33 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 13.59     One year: 15.29
Support: Support1: 9.29    Support2: 7.73
Resistance: Resistance1: 11.64    Resistance2: 13.09
Pivot: 11.01
Moving Average: MA(5): 11.03     MA(20): 11.10
MA(100): 8.26     MA(250): 10.28
MACD: MACD(12,26): 0.34     Signal(9): 0.47
Stochastic oscillator: %K(14,3): 37.19     %D(3): 36.04
RSI: RSI(14): 52.11
52-week: High: 17.83  Low: 5.36  Change(%): -27.9
Average Vol(K): 3-Month: 20168  10-Days: 15043

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CNCE has closed above bottom band by 41.4%. Bollinger Bands are 40.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to CNCE's normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Concert Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert announces closing of public offering and full exercise of underwriters’ option to purchase additional shares.

Concert Pharmaceuticals Announces Pricing of Public Offering
LEXINGTON, Mass.--(BUSINESS WIRE)---- $CNCE #CNCE--Concert Pharmaceuticals Announces Pricing of Public Offering

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 23.84
Shares Float (M) 19.14
% Held by Insiders 8.44
% Held by Institutions 52.81
Shares Short (K) 572
Shares Short P. Month (K)

Stock Financials

EPS -3.330
Book Value (p.s.) 5.000
PEG Ratio
Profit Margin
Operating Margin -7253.95
Return on Assets (ttm) -27.1
Return on Equity (ttm) -51.5
Qtrly Rev. Growth -9.1
Gross Profit (p.s.) -1.369
Sales Per Share
EBITDA (p.s.) -3.209
Qtrly Earnings Growth
Operating Cash Flow (M) -49.30
Levered Free Cash Flow (M) -17.32

Stock Valuations

P/E -3.26
P/E Growth Ratio -0.02
P/BV 2.17
P/S 217.39
P/CF -5.26

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.